QTL | Peak | 2 LOD interval | sex |
a
|
d
| d/a | VP explained |
|---|
LS1.1 | 6A-B | 1A – 10F | females | 0.2 |
1.8
| 8.39 | 0.01 |
LS2.1 | 31F-32B | 30F – 35B | males |
4.8
|
5.1
| 1.06 | 0.21 |
LS2.2 | 30E | 29C – 36A | females | -0.1 |
2.3
| 29.84 | 0.01 |
LS2.3 | 49F-50D | 45A – 52F | females | -0.9 |
3.6
| 4.07 | 0.03 |
LS3.1 | 66D | 65B – 67C | females |
2.9
|
2.1
| 0.73 | 0.04 |
LS3.2 | 85E-86B | 73D – 87E | females |
-2.6
|
4.9
| 1.89 | 0.08 |
LS3.3 | 94D | 92F – 98B | females | 0.2 |
2.6
| 17.03 | 0.01 |
- QTL name, cytological position with peak and 2 LOD interval, sex affected and estimates of additive (a) and dominance (d) effects on life span (in days), dominance ratio (d/a) and proportion of phenotypic variance VP explained by the QTL.
- Negative values of a indicate the LI4 line has the increasing allele at this QTL. This was accounted for in the calculation of the dominance ratio. Significant QTL effects (at P < 0.05) are shown in boldface. All QTL shown are supported both by composite interval mapping and single marker analysis.
